Message from Managing Director
I bring warm greetings from apex.
The last 27 years have been an immensely gratifying experience. What started
as a small unit catering to local market, today apex is a significant
player in the Indian pharmaceutical industry. We have evolved as an organization
whose strengths are its People, Processes and Customer Focus and we have
established our leadership in the market by leveraging these strengths.
The Indian pharmaceutical industry is poised for exponential growth. Globalization
has opened up new opportunities and India with its inherent strengths
is set to be the biggest beneficiary.
Our company’s ambitious plans for the future will be fuelled by the 4 growth engines
namely - New product Launches, Entry of Products in Global Regulated Markets, Contract
Manufacturing and Contract Research.
Our successful marketing track record should make us an attractive proposition
for multinational pharma companies looking to introduce their products
in India.
The company is setting up modern manufacturing facilities conforming to
international standards. This will provide exclusive production facilities for oral
liquids, tablets/ capsules and topicals, apart from giving us the additional
capacity to undertake contract manufacturing. These units are built to
international specifications and will be able to handle export orders
from the US and Europe in addition to our existing markets in Asia and
Africa.
Apex will soon have Research & Development division which will be
reorganized as a separate SBU with independent business objectives. The
upcoming Greenfield R&D facility being established will attract partnerships
from international pharmaceutical companies for contract research apart
from addressing the in-house research initatives.
Leveraging our innate strength along with the new initiatives, I am sure
will enable apex laboratories to emerge as a global leader in the foreseeable
future.
Sincerely,
S.S.Vanangamudi
Managing Director.
